X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-11-20 | RDGL | Vivos Inc | Weeks Brad Allan | Pres | P - Purchase | $0.04 | +150,000 | 1,697,204 | +10% | +$5,790 | ||||||
2026-11-20 | RDGL | Vivos Inc | Korenko Michael K | CEO | P - Purchase | $0.05 | +200,000 | 11,835,090 | +2% | +$9,820 | ||||||
2026-11-19 | MODD | Modular Medical, Inc. | Manchester Management Co LLC | CEO | P - Purchase | $2.03 | +10,000 | 168,811 | +6% | +$20,256 | ||||||
| DM | 2026-02-20 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $37.86 | -111,412 | 122,740 | -48% | -$4,217,541 | |||||
2026-11-19 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | P - Purchase | $96.67 | +7,900 | 29,772 | +36% | +$763,706 | ||||||
| M | 2026-11-17 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $2.46 | +65,192 | 1,140,182 | +6% | +$160,205 | |||||
2026-11-17 | TLSI | Trisalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $2.20 | +10,000 | 82,510 | +14% | +$22,000 | ||||||
| DM | 2026-11-17 | LNSR | Lensar, Inc. | O'Farrell Elizabeth G. | Dir | S - Sale+OE | $5.12 | -33,175 | 67,368 | -33% | -$169,989 | |||||
2026-11-18 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $28.46 | -15,000 | 430,215 | -3% | -$426,921 | ||||||
2026-11-17 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $0.58 | +30,000 | 1,429,268 | +2% | +$17,400 | ||||||
2026-11-18 | SRTS | Sensus Healthcare, Inc. | Cornish Megan | Dir | P - Purchase | $2.28 | +2,200 | 34,200 | +7% | +$5,016 | ||||||
2026-11-17 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $2.24 | +81,575 | 378,452 | +27% | +$182,973 | ||||||
| D | 2026-11-16 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $250.00 | -861 | 71,602 | -1% | -$215,250 | |||||
2026-11-17 | RMD | Resmed Inc | De Witte Jan | Dir | S - Sale | $237.00 | -429 | 3,772 | -10% | -$101,673 | ||||||
2026-11-18 | NPCE | Neuropace Inc | Huennekens R Scott | Dir | P - Purchase | $8.29 | +12,500 | 12,500 | New | +$103,661 | ||||||
| DM | 2026-11-16 | NEPH | Nephros Inc | Amron Arthur H | Dir | P - Purchase | $2.94 | +7,500 | 195,183 | +4% | +$22,075 | |||||
2026-11-16 | SGP | Spyglass Pharma, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $32.43 | +1,000 | 8,022,117 | 0% | +$32,430 | ||||||
| M | 2026-11-16 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $23.31 | -16,854 | 655,531 | -3% | -$392,877 | |||||
2026-11-16 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | GC | S - Sale | $23.32 | -3,725 | 200,886 | -2% | -$86,858 | ||||||
| M | 2026-11-16 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $23.29 | -6,380 | 204,870 | -3% | -$148,574 | |||||
2026-11-16 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $10.64 | -20,685 | 241,305 | -8% | -$220,006 | ||||||
| D | 2026-11-16 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale+OE | $16.22 | -775 | 54,143 | -1% | -$12,571 | |||||
2026-11-16 | DXCM | Dexcom Inc | Brown Michael Jon | EVP Chief Legal Compliance Off | S - Sale | $83.46 | -1,700 | 95,034 | -2% | -$141,882 | ||||||
| A | 2026-11-17 | DAVI | Davion Healthcare Plc | King Susan M | Dir | P - Purchase | $0.98 | +10,000 | 15,000 | +200% | +$9,800 | |||||
2026-11-16 | ICU | Seastar Medical Holding Corp | Messinger Michael | CFO | P - Purchase | $0.85 | +2,500 | 5,000 | +100% | +$2,125 | ||||||
2026-11-16 | ICU | Seastar Medical Holding Corp | Chung Kevin | Chief Medical Officer | P - Purchase | $0.84 | +7,800 | 35,821 | +28% | +$6,589 | ||||||
2026-11-16 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | P - Purchase | $6.79 | +14,602 | 615,323 | +2% | +$99,146 | ||||||
2026-11-17 | NPCE | Neuropace Inc | Williams Patrick F. | CFO | P - Purchase | $8.34 | +11,891 | 79,399 | +18% | +$99,148 | ||||||
2026-11-17 | NPCE | Neuropace Inc | Becker Joel | CEO | P - Purchase | $8.35 | +11,891 | 149,891 | +9% | +$99,293 | ||||||
2026-11-16 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | P - Purchase | $2.40 | +30,000 | 1,250,293 | +2% | +$72,108 | ||||||
2026-11-17 | SSII | Ss Innovations International, Inc. | Sudhir Srivastava | COB, CEO, 10% | P - Purchase | $3.00 | +100,000 | 108,550,928 | 0% | +$300,000 | ||||||
2026-11-13 | KRMD | Koru Medical Systems, Inc. | Schiller Eric | CTO | P - Purchase | $3.63 | +8,546 | 13,546 | +171% | +$31,022 | ||||||
| D | 2026-11-13 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $0.65 | +307,693 | 1,399,268 | +28% | +$200,000 | |||||
| D | 2026-11-13 | NSPR | Inspiremd, Inc. | Lawless Michael A | CFO | P - Purchase | $0.65 | +115,385 | 807,080 | +17% | +$75,000 | |||||
| D | 2026-11-13 | NSPR | Inspiremd, Inc. | Berman Michael | Dir | P - Purchase | $0.65 | +76,923 | 674,503 | +13% | +$50,000 | |||||
| D | 2026-11-13 | NSPR | Inspiremd, Inc. | Slosman Marvin | CEO, Pres | P - Purchase | $0.65 | +46,154 | 3,602,812 | +1% | +$30,000 | |||||
| D | 2026-11-13 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $0.65 | +153,846 | 988,324 | +18% | +$100,000 | |||||
2026-11-16 | TLSI | Trisalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | S - Sale | $2.43 | -544 | 127,450 | 0% | -$1,322 | ||||||
2026-11-17 | DAVI | Davion Healthcare Plc | King Susan M | Dir | P - Purchase | $0.10 | +10,000 | 15,000 | +200% | +$980 | ||||||
| D | 2026-11-16 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | S - Sale+OE | $86.33 | -16,722 | 62,132 | -21% | -$1,443,527 | |||||
2026-11-16 | DAVI | Davion Healthcare Plc | Sluyters Julian | Dir | P - Purchase | $1.06 | +25,000 | 30,000 | +500% | +$26,490 | ||||||
2026-11-16 | RNXT | Renovorx, Inc. | Agah Ramtin | Exec COB, CMO | P - Purchase | $0.93 | +50,000 | 848,460 | +6% | +$46,485 | ||||||
| D | 2026-11-12 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $246.32 | -44,917 | 71,602 | -39% | -$11,063,782 | |||||
2026-11-12 | TLSI | Trisalus Life Sciences, Inc. | Wahlstrom Mats | Dir | P - Purchase | $2.24 | +50,000 | 3,012,030 | +2% | +$112,000 | ||||||
| D | 2026-11-10 | NXGL | Nexgel, Inc. | Kieser Brian Joseph | Interim CEO, 10% | P - Purchase | $5.50 | +133,216 | 133,216 | New | +$732,688 | |||||
| D | 2026-11-10 | NXGL | Nexgel, Inc. | Glassman Steven Mark | Dir | P - Purchase | $5.50 | +4,546 | 12,379 | +58% | +$25,003 | |||||
| M | 2026-11-06 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | S - Sale | $1.34 | -3,335,411 | 7,325,577 | -31% | -$4,479,146 | |||||
2026-11-09 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.99 | +40,000 | 7,325,577 | +1% | +$79,600 | ||||||
| DM | 2026-11-12 | ICUI | Icu Medical Inc/De | Finney Elisha W | Dir | S - Sale+OE | $179.00 | -1,765 | 4,871 | -27% | -$315,935 | |||||
| D | 2026-11-11 | HAE | Haemonetics Corp | Maunsell Farris Maryanne | VP, Chief Accounting Officer | S - Sale+OE | $120.99 | -836 | 5,828 | -13% | -$101,148 | |||||
| D | 2026-11-12 | DCTH | Delcath Systems, Inc. | Martell Bridget A | Dir | S - Sale+OE | $21.71 | -22,500 | 0 | -100% | -$488,508 | |||||
| D | 2026-11-11 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.21 | -8,874 | 159,378 | -5% | -$152,681 | |||||
| D | 2026-11-10 | GMED | Globus Medical Inc | Tobin James R | Dir | S - Sale+OE | $75.16 | -41,666 | 0 | -100% | -$3,131,547 | |||||
| D | 2026-11-09 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.00 | -744 | 159,378 | 0% | -$12,649 | |||||
2026-11-09 | STVN | Stevanato Group S.P.A. | Federici William J | Dir | P - Purchase | $13.72 | +20,000 | 78,580 | +34% | +$274,400 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Rtw Investments, LP | 10% | P - Purchase | $5.00 | +1,200,000 | 10,756,063 | +13% | +$6,000,000 | ||||||
2026-11-09 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale | $12.86 | -3,079 | 69,753 | -4% | -$39,602 | ||||||
2026-11-09 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | S - Sale | $12.86 | -7,343 | 175,499 | -4% | -$94,446 | ||||||
| D | 2026-11-09 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $235.35 | -4,993 | 481,893 | -1% | -$1,175,089 | |||||
2026-11-10 | ATEC | Alphatec Holdings, Inc. | Valentine Keith | Dir | P - Purchase | $6.93 | +35,000 | 299,283 | +13% | +$242,550 | ||||||
| D | 2026-11-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale+OE | $55.74 | -38,900 | 251,983 | -13% | -$2,168,286 | |||||
2026-11-09 | HTFL | Heartflow, Inc. | Verghese Vikram | CFO | S - Sale | $53.15 | -3,587 | 149,587 | -2% | -$190,649 | ||||||
2026-11-06 | STVN | Stevanato Group S.P.A. | Morel Donald E Jr | Dir | P - Purchase | $13.07 | +25,000 | 62,424 | +67% | +$326,750 | ||||||
2026-11-06 | ATRC | Atricure, Inc. | Johnson B Kristine | Dir | S - Sale | $58.48 | -2,452 | 53,502 | -4% | -$143,393 | ||||||
2026-11-04 | TCMD | Tactile Systems Technology Inc | Burke William W | Dir | S - Sale | $27.00 | -5,000 | 50,041 | -9% | -$135,000 | ||||||
| D | 2026-11-05 | BDX | Becton Dickinson & Co | Polen Thomas E Jr | COB, CEO, Pres | S - Sale+OE | $210.00 | -2,993 | 110,163 | -3% | -$628,530 | |||||
| AD | 2026-11-04 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale+OE | $24.88 | -36,241 | 204,611 | -15% | -$901,844 | |||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Fain Eric S | Dir | P - Purchase | $5.00 | +20,000 | 119,630 | +20% | +$100,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Pacitti David | Dir | P - Purchase | $5.00 | +20,000 | 74,750 | +37% | +$100,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $5.00 | +5,000 | 1,514,519 | 0% | +$25,000 | ||||||
2026-11-09 | OBIO | Orchestra Biomed Holdings, Inc. | Taylor Andrew Lawrence | CFO | P - Purchase | $5.00 | +1,000 | 590,989 | 0% | +$5,000 | ||||||
2026-11-06 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $325.32 | -550,000 | 13,917,258 | -4% | -$178,924,731 | ||||||
| D | 2026-11-05 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -382 | 159,378 | 0% | -$6,508 | |||||
2026-11-06 | PRCT | Procept Biorobotics Corp | Sharma Pooja | Chief Strat, Marketing Officer | S - Sale | $19.71 | -4,710 | 106,471 | -4% | -$92,853 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $25.30 | -75,000 | 672,385 | -10% | -$1,897,643 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $24.80 | -36,241 | 204,611 | -15% | -$898,802 | ||||||
2026-11-04 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $25.00 | -3,247 | 211,250 | -2% | -$81,175 | ||||||
| D | 2026-11-04 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $253.00 | -2,500 | 37,406 | -6% | -$632,500 | |||||
2026-11-03 | KMTS | Kestra Medical Technologies, Ltd. | Moran Timothy P. | Chief Business Officer | S - Sale | $29.56 | -3,192 | 63,153 | -5% | -$94,352 | ||||||
2026-11-04 | GMED | Globus Medical Inc | Rhoads Ann D | Dir | S - Sale | $85.00 | -5,000 | 35,384 | -12% | -$425,000 | ||||||
2026-11-03 | TCMD | Tactile Systems Technology Inc | King Laura G. | Dir | S - Sale | $25.00 | -4,800 | 20,769 | -19% | -$120,000 | ||||||
2026-11-04 | ATRC | Atricure, Inc. | Privitera Salvatore | Chief Technical Officer | S - Sale | $65.00 | -8,404 | 134,341 | -6% | -$546,260 | ||||||
2026-11-04 | PLSM | Pulsenmore Ltd. | Sonnenschein Elazar | CEO | P - Purchase | $1.70 | +9,259 | 892,421 | +1% | +$15,740 | ||||||
| D | 2026-11-02 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale+OE | $20.89 | -20,000 | 97,130 | -17% | -$417,820 | |||||
| D | 2026-11-03 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $15.15 | -747 | 22,489 | -3% | -$11,317 | |||||
2026-11-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $16.90 | -370 | 54,143 | -1% | -$6,253 | ||||||
2026-11-02 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $13.24 | -660 | 202,567 | 0% | -$8,738 | ||||||
2026-11-02 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Limb Recon | S - Sale | $9.07 | -150 | 50,769 | 0% | -$1,361 | ||||||
| D | 2026-10-30 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale+OE | $238.97 | -44,436 | 37,328 | -54% | -$10,618,980 | |||||
2026-11-02 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $5.74 | -15,000 | 1,106,402 | -1% | -$86,100 | ||||||
2026-10-29 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $22.11 | -29,665 | 240,852 | -11% | -$655,745 | ||||||
2026-10-29 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | Chief Op, Financial Officer | S - Sale | $22.50 | -3,738 | 214,497 | -2% | -$84,105 | ||||||
| D | 2026-10-30 | CARL | Carlsmed, Inc. | Bertolini Jeffrey | COO | S - Sale+OE | $15.80 | -243 | 22,489 | -1% | -$3,839 | |||||
2026-10-30 | ATEC | Alphatec Holdings, Inc. | Demski David M | Dir | P - Purchase | $6.81 | +60,000 | 491,635 | +14% | +$408,600 | ||||||
2026-10-30 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $2.27 | +18,000 | 10,620,988 | 0% | +$40,860 | ||||||
| M | 2026-10-28 | ANGO | Angiodynamics Inc | Trowbridge Stephen A | EVP, CFO | S - Sale | $12.26 | -25,335 | 280,461 | -8% | -$310,688 | |||||
| DM | 2026-10-27 | KMTS | Kestra Medical Technologies, Ltd. | Mahboob Vaseem | CFO | S - Sale+OE | $30.30 | -79,500 | 60,609 | -57% | -$2,408,590 | |||||
| D | 2026-10-27 | KMTS | Kestra Medical Technologies, Ltd. | Umberger Traci S | See Remarks | S - Sale+OE | $30.03 | -30,000 | 195,825 | -13% | -$900,882 | |||||
2026-10-29 | UTMD | Utah Medical Products Inc | Cornwell Kevin L | COB, CEO | P - Purchase | $66.75 | +1,000 | 189,472 | +1% | +$66,750 | ||||||
2026-10-27 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $22.00 | -2,650 | 174,740 | -1% | -$58,300 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |